Overview
- 17 inspections across 17 sites are on record.
- 53 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2015-11-19.
At a glance
Inspections
17
Sites
17
Observations
53
Career since
Sep 2011
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Beijing Taiyang Pharmaceutical Industry Co Ltd | 19 Nov 2015 | Human Drugs | On file |
| Mylan Laboratories Limited | 25 Mar 2015 | Human Drugs | View 483 → |
| Wockhardt Limited | 17 Mar 2015 | Human Drugs | View 483 → |
| Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. | 26 Sep 2014 | Human Drugs | On file |
| Nanjing White Whale Pharmaceutical Co., Ltd | 19 Sep 2014 | Human Drugs | On file |
Sites inspected
Beijing Taiyang Pharmaceutical Industry Co LtdChaoyang, China1 insp.
Mylan Laboratories LimitedNasik, Nashik, India1 insp.
Wockhardt LimitedAurangabad, India1 insp.
Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd.Taizhou, China1 insp.
Nanjing White Whale Pharmaceutical Co., LtdNanjing, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Lloyd D Payne6 shared
Nadeem I Chaudhry4 shared
Eric M Mueller2 shared
Peter E Baker1 shared
Merideth K Rose1 shared
Carmelo Rosa1 shared
Full investigator report
Get the verbatim findings behind Rafael E Arroyo's 53 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site